Protagonist Therapeutics, Inc Business Finance Contracts & Agreements
14 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (2)
- Registration Rights Agreements (1)
- Stock Agreements (1)
- Underwriting Agreements (6)
- Warrant Agreements (3)
- Underwriting Agreement, dated April 4, 2023 (Filed With SEC on April 10, 2023)
- Underwriting Agreement, dated June 15, 2021 (Filed With SEC on June 17, 2021)
- Underwriting Agreement, dated December 10, 2020 (Filed With SEC on December 11, 2020)
- Underwriting Agreement, dated as of May 11, 2020 (Filed With SEC on May 12, 2020)
- Exchange Agreement between Protagonist Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P.,... (Filed With SEC on December 31, 2018)
- Form of Warrant (Filed With SEC on December 31, 2018)
- Form of Registration Rights Agreement (Filed With SEC on August 7, 2018)
- Form of Class B Common Stock Purchase Warrant (Filed With SEC on August 7, 2018)
- Form of Class A Common Stock Purchase Warrant (Filed With SEC on August 7, 2018)
- Underwriting Agreement, dated as of October 11, 2017, by and among Protagonist Therapeutics, Inc., Leerink Partners LLC and Barclays Capital Inc (Filed With SEC on October 13, 2017)
- PROTAGONIST THERAPEUTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY 28, 2016 APPROVED BY THE STOCKHOLDERS:JULY 31, 2016 (Filed With SEC on August 1, 2016)
- PROTAGONIST THERAPEUTICS, INC. THIRD AMENDEDAND RESTATED INVESTOR RIGHTS AGREEMENT July 31, 2016 PROTAGONIST THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS... (Filed With SEC on August 1, 2016)
- PROTAGONIST THERAPEUTICS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 1, 2016)
- PROTAGONIST THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORRIGHTS AGREEMENT July 10, 2015 PROTAGONIST THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS... (Filed With SEC on July 11, 2016)
